ArticleOrthopaedic journal of sports medicine2025
Osteochondral Allograft Transplantation of the Femoral Head via Surgical Hip Dislocation: Survivorship and Patient Reported Outcome Measures at Minimum 2-Year Follow-Up.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What the papers say.Journal of hip preservation surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Treatment of isolated osteochondral lesions of the femoral head in young patients presents a clinical challenge for orthopaedic surgeons. Nonoperative management is associated with poor patient satisfaction and the development of osteoarthritis, while arthroplasty in young patients raises concerns regarding implant longevity. Purpose: To evaluate patient-reported outcome measures (PROMs) and the rate of conversion to THA after osteochondral allograft (OCA) transplantation via surgical hip dislocation (SHD) for isolated cartilage lesions of the femoral head. Study Design: Case series; Level of evidence, 4. Methods: Patients who underwent femoral head OCA via SHD at our institution between August 2010 and June 2023, with a minimum 2-year follow-up, were retrospectively reviewed. Demographic, perioperative, and complication data were collected prospectively from a registry. The Modified Harris Hip Score (mHHS) and the International Hip Outcome Tool-12 (iHOT-12) were administered pre- and postoperatively. The minimal clinically important difference (MCID) and patient acceptable symptom state (PASS) thresholds established for hip arthroscopy in patients with femoroacetabular impingement were used to assess patient outcomes. Results: A total of 24 patients (54% women; mean age, 22.4 years) were included. The mean lesion size was 488 mm Conclusion: Treatment of femoral head osteochondral lesions with OCA via SHD was associated with significant postoperative improvements in PROMs, with a 25% rate of conversion to hip arthroplasty, at a mean follow-up of 4 years. Increased OCA graft depth was associated with conversion to THA. OCA transplantation provides a versatile treatment option for isolated femoral head osteochondral lesions in young patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.